AFF4 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.601800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.854800E-01
Normal-vs-Stage2
8.484000E-01
Normal-vs-Stage3
5.287900E-02
Normal-vs-Stage4
2.906200E-01
Stage1-vs-Stage2
7.729200E-01
Stage1-vs-Stage3
2.200300E-02
Stage1-vs-Stage4
1.609400E-01
Stage2-vs-Stage3
9.423700E-02
Stage2-vs-Stage4
8.846000E-02
Stage3-vs-Stage4
1.707600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.985400E-01
Normal-vs-AfricanAmerican
7.323400E-01
Normal-vs-Asian
8.105800E-01
Caucasian-vs-AfricanAmerican
4.881400E-01
Caucasian-vs-Asian
8.744400E-01
AfricanAmerican-vs-Asian
4.570800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.592000E-01
Normal-vs-Female
8.760800E-01
Male-vs-Female
9.156800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.826800E-01
Normal-vs-Age(41-60Yrs)
6.446200E-01
Normal-vs-Age(61-80Yrs)
6.333200E-01
Normal-vs-Age(81-100Yrs)
1.959970E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.090600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.573600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.390020E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
8.361900E-04
Age(41-60Yrs)-vs-Age(81-100Yrs)
9.396200E-03
Age(61-80Yrs)-vs-Age(81-100Yrs)
2.293000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.759800E-01
Normal-vs-Daily Drinker
3.083000E-01
Normal-vs-Weekly Drinker
6.611200E-01
Normal-vs-Occasional Drinker
7.595800E-01
Normal-vs-Social Drinker
8.033800E-01
Non Drinker-vs-Daily Drinker
4.753000E-01
Non Drinker-vs-Weekly Drinker
8.809200E-01
Non Drinker-vs-Occasional Drinker
9.001600E-02
Non Drinker-vs-Social Drinker
1.384240E-01
Daily Drinker-vs-Weekly Drinker
4.534000E-01
Daily Drinker-vs-Occasional Drinker
2.322500E-02
Daily Drinker-vs-Social Drinker
4.781600E-02
Weekly Drinker-vs-Occasional Drinker
2.138400E-01
Weekly Drinker-vs-Social Drinker
2.843200E-01
Occasional Drinker-vs-Social Drinker
9.818800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
5.685800E-02
Normal-vs-Grade 2
6.415600E-03
Normal-vs-Grade 3
7.623800E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.028000E-01
Grade 1-vs-Grade 3
4.474000E-01
Grade 1-vs-Grade 4
5.685800E-02
Grade 2-vs-Grade 3
5.596800E-01
Grade 2-vs-Grade 4
6.415600E-03
Grade 3-vs-Grade 4
7.623800E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.132200E-01
Normal-vs-NonDiabetic
8.113400E-01
Diabetic-vs-NonDiabetic
4.662600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.502200E-01
Normal-vs-NoPancreatitis
8.188000E-01
Pancreatitis-vs-NoPancreatitis
6.099400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.517200E-01
Normal-vs-N1
8.617400E-01
N0-vs-N1
8.977800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.353600E-01
Normal-vs-TP53-NonMutant
9.680200E-01
TP53-Mutant-vs-TP53-NonMutant
8.924200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
